Laboratory Research

Neuromyelitis Optica, Part 3: Treatment and Prevention

After discussing NMO pathogenesis, we’ll talk about current treatments, as well as efforts to find better treatments and even prevent NMO attacks

Because NMO patients essentially suffer from inflammation, doctors first try to stop an acute NMO attack with...

Clinical Research, Drug Development, Laboratory Research, People

Neuromyelitis Optica, Part 2: Pathogenesis

Now that we’ve seen how researchers came to the conclusion that NMO differs from MS, let’s take a closer look at the current understanding of its pathogenesis

About three-quarters of NMO patients have the aquaporin-4 antibody, a number that has been steadily...

Clinical Research, Drug Development, Laboratory Research, People

Neuromyelitis Optica, Part 1: The Other Disease

Once thought of as a variant of multiple sclerosis, neuromyelitis optica is now clearly understood to be a different disease

Lea Long still remembers the moment her life changed like it was yesterday. She was in the...

Clinical Research, Drug Development, Laboratory Research, People

Genome-wide Study Brings MS Landscape Into Sharper Focus

New study increases to 110 the number of genes closely linked to MS

The International Multiple Sclerosis Genetics Consortium has announced the discovery of 48 additional variants in...

Laboratory Research

The Many Faces of B Cells

Experimental therapy prompts a closer look at immune cells

Five years ago, just as the global economy plummeted, interest in B cells spiked upward among...

Laboratory Research

Single Calcitriol Dose Beats Back EAE in Mice

Vitamin D zaps inflammatory T cells in the CNS and leads to sustained remission

Just a single dose of calcitriol—the active form of vitamin D—reversed...

Laboratory Research

Stem Cells Enhanced to Generate Myelin-Producing Cells

A new technology enhances stem cells to generate myelin-producing cells. This may allow regenerative therapy in MS and other brain diseases.

A new method of generating embryonic stem cells that can ultimately produce myelin may allow...

Laboratory Research

First-Attack Multiple Sclerosis Targets Gray Matter

A new technique has identified changes in gray matter-related proteins in CSF that distinguished first-attack CIS from established relapsing-remitting MS and from controls

Using a highly sensitive and precise proteomics technique, researchers have discovered...

Clinical Research, Laboratory Research

Nominations Open for Dystel Prize for MS Research

Deadline: October 30, 2013

The John Dystel Prize for Multiple Sclerosis Research is awarded jointly by the National Multiple Sclerosis Society and the American Academy of Neurology (AAN).

Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People

Sleep Boosts Remyelinating Glial Cells

Oligodendrocyte precursor cells proliferate during sleep in mice. Could increasing the pool of this critical cell type tip the balance toward remyelination?

Multiple sclerosis robs neurons of myelin, but replenishment of lost myelin could be improved...

Laboratory Research

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Neuromyelitis Optica, Part 3: Treatment and Prevention

Neuromyelitis Optica, Part 2: Pathogenesis

Neuromyelitis Optica, Part 1: The Other Disease

Genome-wide Study Brings MS Landscape Into Sharper Focus

The Many Faces of B Cells

Single Calcitriol Dose Beats Back EAE in Mice

Stem Cells Enhanced to Generate Myelin-Producing Cells

First-Attack Multiple Sclerosis Targets Gray Matter

Nominations Open for Dystel Prize for MS Research

Sleep Boosts Remyelinating Glial Cells

Pages

MSDF Footer

Search form

Laboratory Research

Pages